Test description
The V617F mutation is seen in a number of myeloproliferative disorders such as polycythaemia vera, essential thrombocytosis and idiopathic myelofibrosis.
Test information
Test name
Quantitative JAK2 V617F
Clinical indication
To aid in the differential diagnosis and prognostic risk classification for myeloproliferative neoplasms, e.g. polycythaemia vera, essential thrombocythaemia and primary myelofibrosis
Gene(s)
JAK2
Method
PCR genotyping
Turn around time
2 weeks
Medicare eligibility
73325 – criteria apply
Price
If not MBS eligible please contact 1800 822 999 for details
Test request form
Standard pathology request form
Sample type
Blood 10mL EDTA tube or Bone Marrow 4mL EDTA tube
Collection type
Blood or bone marrow
Special instructions
None